L3VLUP
ProSign in

MYGN · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

MYGNLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • MYGN
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterMYGNLLY
Q3 20206 holders, $99m33 holders, $14.1bn
Q4 20207 holders, $170m29 holders, $17.3bn
Q1 20215 holders, $195m24 holders, $23.0bn
Q2 20214 holders, $190m24 holders, $27.8bn
Q3 20213 holders, $191m31 holders, $29.9bn
Q4 20212 holders, $106m31 holders, $34.7bn
Q1 20222 holders, $102m24 holders, $35.3bn
Q2 20223 holders, $72m33 holders, $42.7bn
Q3 20223 holders, $193m31 holders, $43.4bn
Q4 20222 holders, $77m31 holders, $46.6bn
Q1 20235 holders, $388m33 holders, $44.3bn
Q2 20236 holders, $368m37 holders, $59.6bn
Q3 20232 holders, $101m44 holders, $67.6bn
Q4 20233 holders, $286m45 holders, $73.6bn
Q1 20243 holders, $332m41 holders, $95.3bn
Q2 20247 holders, $490m43 holders, $110bn
Q3 20245 holders, $456m45 holders, $107bn
Q4 20242 holders, $95m46 holders, $93.9bn
Q1 20253 holders, $56m42 holders, $98.4bn
Q2 20251 holders, $24m43 holders, $93.2bn
Q3 20251 holders, $33m39 holders, $86.7bn
Q4 20251 holders, $28m41 holders, $123bn
Q1 20262 holders, $25m39 holders, $106bn
Q2 20262 holders, $19m44 holders, $132bn
MYGN

Myriad Genetics Inc

Holders
3
Reported value
$332m
Buyers
2
Sellers
1

Breadth +1 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUP
LLY

Eli Lilly & Co

Holders
41
Reported value
$95.3bn
Buyers
15
Sellers
27

Breadth -12 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q1 2024

Among the 42 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only MYGN (1)

Glenview Capital Management LLC

Only LLY (39)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Balyasny Asset Management LLC, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Caxton Associates LLP, Citadel Advisors LLC, Coatue Management LLC, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), GAMCO Investors Inc, Holocene Advisors LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Moore Capital Management LP, Neuberger Berman Group LLC, and 14 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →